Proportion with β-blocker intensification in preceding 30-day window | Adjusted OR | 95% CI | P Value | ||
---|---|---|---|---|---|
CASE (n = 1674) | CONTROL (n = 1674) | ||||
Total | 2.33% (n = 39) | 1.61% (n = 27) | 1.36 | 0.81-2.27 | 0.246 |
LVSD | 2.44% (n = 14) | 2.26% (n = 13) | 1.13 | 0.50-2.54 | 0.770 |
No LVSD | 2.27% (n = 25) | 1.27% (n = 14) | 1.54 | 0.78-3.04 | .221 |